Stress Urinary Incontinence
Conditions
Interventions
The experimental group:Conventional therapy+Intramuscular injection of parecoxib sodium
Sponsors
South Renji Hospital
Eligibility
Sex/Gender
Female
Age
25 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Female aged 25 and 75 years with stress urinary incontinence; 2. Accept the transobturator middle urethral sling treatment; 3. General anesthesia during surgery; 4. Patients are willing and able to correctly complete the VAS score form.
Exclusion criteria
Exclusion criteria: 1. Liver or kidney disease (Defined as serum AST, ALT, bilirubin, creatinine exceeded the upper limit of the normal reference value of 50%); 2. A clear history of heart diseaseIncluding cardiac insufficiency, angina, myocardial infarction, arrhythmia, etcFailed to control the high blood pressure or low blood pressure (Sitting diastolic blood pressure lower than 60mmHg); 3. A history of gastrointestinal bleeding or perforation after use of NSAIDs; 4. Allergic rhinitis and urticaria after use of NSAIDs; 5. Patients with inflammatory bowel disease; 6. Allergic to parecoxib sodium; 7. Application of other NSAIDs and/or expected to use such drugs during the experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction of pain control; | — |
Countries
China
Contacts
Public ContactDr. Jianwei Lv
South Renji Hospital
Outcome results
None listed